Medication info

Potasol Injection

Prescription medicationInjections
Ingredient · strength
L-Isoleucine›6775mg / 1000mLL-Leucine›8275mg / 1000mLL-Lysine Hydrochloride›6934mg / 1000mLL-Methionine›450mg / 1000mLL-Phenylalanine›600mg / 1000mLL-Threonine›3375mg / 1000mLL-Tryptophan›375mg / 1000mLL-Valine›6300mg / 1000mLL-Arginine›4500mg / 1000mLL-Histidine›1875mg / 1000mLL-Alanine›5475mg / 1000mLGlycine›6750mg / 1000mLL-Proline›6000mg / 1000mLL-Serine›3450mg / 1000mLAcetylcysteine›337mg / 1000mL
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
This injection is filled with a colorless to pale yellow liquid in a colorless transparent vial with a rubber stopper.
Packaging
250 milliliters / vial x 1
Approval status
Active

MFDS item code 199200081 · Notified 1992.08.21

Summary

Main use
Amino acid supplementation in patients with hepatic impairment; improvement of encephalopathy caused by acute or chronic hepatic impairment
Who uses it
Adults · Children
Adult dosage
○Adults: Administer by intravenous infusion a maximum total amino acid dose of 1~1.5 g per kg of body weight per day. ○Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is recommended; as a general rule, infuse at 30~40 drops per minute.
Children's dosage
For children, older adults, and burn patients with high protein requirements, adjust the dose and infusion rate appropriately.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Amino acid supplementation in patients with hepatic impairment; improvement of encephalopathy caused by acute or chronic hepatic impairment

View approved original text

This medication helps improve encephalopathy caused by acute and chronic liver failure. It also supplies the amino acids needed for patients with liver dysfunction, supporting liver function recovery. It is effective in alleviating symptoms associated with liver dysfunction and improving the overall health status of patients.

Dosage and Administration

Adult dosage

○Adults: Administer by intravenous infusion a maximum total amino acid dose of 1~1.5 g per kg of body weight per day. ○Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is recommended; as a general rule, infuse at 30~40 drops per minute.

Children's dosage

For children, older adults, and burn patients with high protein requirements, adjust the dose and infusion rate appropriately.

Precautions

This medication should be used strictly according to a doctor's instructions and should not be taken or stopped arbitrarily. Patients with certain conditions such as severe renal failure or hypernitrogenemia, patients with metabolic problems related to amino acids, or patients with heart failure or pulmonary edema should not use this medication. This medication may contain electrolytes such as sodium or magnesium, so patients who are sensitive to these ingredients or have related diseases should exercise caution. Especially patients with poor kidney function or heart disease should be careful when administering it, as it may affect the body's fluid balance. Rarely, this medication may cause skin rashes or gastrointestinal symptoms such as nausea, vomiting, arrhythmias, or changes in blood pressure. Rapid administration in large amounts may lead to metabolic disorders such as acidosis, so attention should be paid to the rate and quantity of administration. Allergic reactions or asthma attacks may occur, so patients with a prior history of allergies should be particularly cautious. The safety of this medication has not been fully established in pregnant women, children, and elderly individuals; therefore, it should be used carefully under a doctor's discretion if necessary. Additionally, this medication may interact with other medications, so it is essential to inform healthcare providers about any other medications being taken. Maintain aseptic conditions during administration, and do not use if the solution is discolored or abnormal, and follow the prescribed storage methods.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • tachycardia
  • hypertension
  • acidosis
  • chills
  • fever
Show 27 more
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary spasm
  • peripheral vascular dilation
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogen retention
  • hyperammonemia
  • sensory loss
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air and should preferably be kept at room temperature. Avoid places that are too hot or too cold, and keep it in a cool place away from direct sunlight.

Appearance and packaging

Appearance

This injection is filled with a colorless to pale yellow liquid in a colorless transparent vial with a rubber stopper.

Package unit

250 milliliters / vial x 1

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.